Drug Approvals
🇺🇸 FDA Page 8FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 85–96 of 665 articles
FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer
FDA · oncology · 5 min
Dr. Sarah MitchellThe Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals
FDA · 5 min
Dr. Sarah MitchellPharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut
FDA · 8 min
Dr. Sarah MitchellAntibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
FDA · lung cancer · 6 min
Dr. Sarah MitchellAbivax Ulcerative Colitis Drug Shows Strong Efficacy, But Cases of Cancer Raise Concerns
ulcerative colitis · 5 min
Dr. Sarah MitchellFDA Flashback: Key Breast Cancer Decisions from April 2026
FDA · breast cancer · 7 min
Dr. Sarah MitchellFDA Shakeup: Høeg's Departure and Amgen Drug Controversy
FDA · 5 min
Dr. Sarah MitchellKailera's Triple-G Drug: A Potential Game-Changer in Pharma
FDA · 5 min
Dr. Sarah MitchellASCO Preview: Akeso's Ivonescimab Under Scrutiny
FDA · oncology · 6 min
Dr. Sarah MitchellAstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma
FDA · breast cancer · 5 min
Dr. Sarah MitchellDrug Discovery USA 2026: What to Expect
FDA · 6 min
Dr. Sarah MitchellPharma in Focus: Regulatory Updates You Need to Know
FDA · 5 min
Dr. Sarah MitchellExplore intelligence